Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines
Open Access
- 11 December 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 37 (1) , 280-286
Abstract
Carbonic anhydrase IX/XII (CA IX/XII), are cell-surface enzymes typically expressed by cancer cells as a form of adaptation to hypoxia and acidosis. It has been widely reported that these proteins play pivotal roles in cancer progression fostering cell migration, aggressiveness and resistance to first line chemo- and radiotherapies. CA IX has emerged as a promising target in cancer therapy and several approaches and families of compounds were characterised in the attempt to find optimal targeting by inhibiting of the high catalytic activity of the enzyme. In the present work, different cell lines representing glioblastoma, bladder and pancreatic cancer have been exploited to compare the inhibitory and antiproliferative effect of primary sulphonamide acetazolamide (AAZ), the Phase Ib/II clinical grade sulphonamide SLC-0111, and a membrane-impermeant positively charged, pyridinium-derivative (C18). New hints regarding the possibility to exploit CA inhibitors in these cancer types are proposed.Keywords
Funding Information
- Italian Ministry for Research (2017XYBP2R)
- Associazione Italiana per la Ricerca sul Cancro (23151)
This publication has 31 references indexed in Scilit:
- Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer MetastasisJournal of Medicinal Chemistry, 2011
- Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activityOncology Reports, 2010
- Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic disseminationInternational Journal of Cancer, 2010
- Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1α, GLUT1, and CAIXVirchows Archiv, 2010
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activatorsNature Reviews Drug Discovery, 2008
- Chronic Hypoxia Decreases Synthesis of Homologous Recombination Proteins to Offset Chemoresistance and RadioresistanceCancer Research, 2008
- Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and InvasionCancer Research, 2004
- Benzolamide is not a Membrane-impermeant Carbonic Anhydrase InhibitorJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitroProceedings of the National Academy of Sciences of the United States of America, 2000
- Acute hypoxia in tumors: Implications for modifiers of radiation effectsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986